Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

Medical Communications | United Nations, WHO, healthcare access, mental health, noncommunicable diseases, primary care

The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental health challenges and noncommunicable diseases …

Feature

Rare diseases – spinal muscular atrophy

Medical Communications | gene therapy, medical communications, muscle and motor function, muscle weakness, rare diseases, sma

Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can lead to difficulties in activities …

Feature

Could targeting the molecular causes of infertility finally transform IVF success rates?

Medical Communications, Research and Development | Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility

By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …

Feature

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

Medical Communications | MHRA, NHS, NICE, Wellcome, digital technologies, medical communications, mental health

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together with other forms of care, …

Feature

Five Facts about spinal muscular atrophy

Medical Communications | Five Facts, Neurology, early diagnosis, five types, gene therapy, muscle weakness, spinal muscular atrophy

1 Spinal muscular atrophy (SMA) is a genetic disease involving the loss of motor neurons in the spinal cord.1 Its …

Feature

Safeguarding health and well-being for employees – the value of occupational health services

Medical Communications | Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels

With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …

Feature

Men’s health – a new report from the Department of Health and Social Care

Medical Communications | Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health

The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …

Feature

Healing the fracture in the system: the case for universal fraction liaison services access

Medical Communications, Research and Development | Osteoporosis

By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …

Feature

Five Facts about antimicrobial resistance

Medical Communications | Antimicrobial resistance (AMR), Five Facts

1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …

Feature

A community-first future: which pathways will get us there?

Business Services | Gateway to Local Adoption, NHS, Visions4Health, pharmacy

In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …

Feature

Von Willebrand disease – increasing awareness and access to vital care

Medical Communications, Research and Development | European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …

Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

Research and Development | EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

Medical Communications, Research and Development | Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Five Facts about men’s mental health

Medical Communications | Five Facts, mental health, men’s mental health

1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …

Feature

Is this an Oppenheimer moment for the life sciences industry?

Business Services, Market Access, Market Access Consultancy, Sales and Marketing | NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026